EGCG potently inhibited BCR/ABL oncoprotein and the JAK2/STAT3/AKT pathway in BCR/ABL+ CML cell lines [7]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.